Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

india-pharmacy

  1. Home>
  2. News>
  3. india-pharmacy>
  4. Page 14

India’s Generic Semaglutide Boom Reshapes Global GLP-1 Market

  • Post published:June 15, 2026
  • Post category:News

Indian generic drugmakers have launched a wave of affordable semaglutide products following the expiry of Novo Nordisk's key patents, with over 50 brands expected in the coming months and prices…

Continue Reading India’s Generic Semaglutide Boom Reshapes Global GLP-1 Market

A Guide to Verifying WHO-GMP Certification for Indian Generic Medicines

  • Post published:June 12, 2026
  • Post category:Knowledge

When sourcing generic medicines from India, one of the most important quality indicators is WHO-GMP (World Health Organization — Good Manufacturing Practices) certification. But how do you actually verify whether…

Continue Reading A Guide to Verifying WHO-GMP Certification for Indian Generic Medicines

CDSCO Tightens Drug Quality: Outsourced Audits, 1,500 Experts, Tighter Safety Rules

  • Post published:June 11, 2026
  • Post category:News

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is implementing one of the most ambitious regulatory overhauls in its history. In a series of coordinated actions between February…

Continue Reading CDSCO Tightens Drug Quality: Outsourced Audits, 1,500 Experts, Tighter Safety Rules

How CDSCO Ensures Quality of Generic Medicines in India: A Complete Guide

  • Post published:June 10, 2026
  • Post category:Knowledge

When you buy generic medicines from India, one question naturally arises: How do I know they are safe and effective? The answer lies with India's central drug regulatory authority —…

Continue Reading How CDSCO Ensures Quality of Generic Medicines in India: A Complete Guide
  • Go to the previous page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 19
  • Go to the next page

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
    September 1, 2026/
    0 Comments
  • India Pushes for Pharma Market Access in Argentina and Brazil
    August 31, 2026/
    0 Comments
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
    August 30, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
  • India Pushes for Pharma Market Access in Argentina and Brazil
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
  • CBN and PHARMEXCIL Sign MoU on Controlled Substances Exports
  • Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve